-
Charges
A charge with Hdfc Bank Limited of Rs. 2.15 Cr registered on 30 Sep 2021 with Charge ID 100495156 was modified on 13 Nov 2025. was recorded as a recent event.
-
Charges
Progress on A charge registered on 06 Jun 2018 via Charge ID 100181424 with Others was fully satisfied on 31 Oct 2025. was documented.
-
Annual General Meeting
The activity Alpine Biomedicals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.
-
Balance Sheet
Alpine Biomedicals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was recorded as a recent event.
-
Charges
A charge with Others amounted to Rs. 4.50 Cr with Charge ID 100968782 was registered on 12 Jul 2024. was recorded as a recent event.
-
Director Appointment
The activity Abhinav Goyal was appointed as a Director was appointed as a Director on 01 Jan 2023 & has been associated with this company since 3 years 23 days . was completed.
Alpine Biomedicals Private Limited, a active private limited company, was established on 06 April 2017 in Ambala, Haryana, India. Engaging in medical consumables & supplies within the manufacturing sector, it holds CIN: U85200HR2017PTC068487. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹1.00 Cr.
It upholds a compliant status. Employing 15 professional, Its leadership includes Abhinav Goyal (Director), Amrita Sundaram (Director), Gaurav Garg (Director). Past directors included Amrita Sundaram, Anuja Goyal. It holds ₹6.65 Cr open charges and ₹1.00 M settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Plot No 348, Sector 2, Industrial Growth Centre, Hsidc, Saha, Ambala, Haryana, 133104.
Company Details
- CIN/LLPIN
U85200HR2017PTC068487
- Registration Number
068487
- Incorporation Date
06 April 2017
- Authorized Capital
₹1.00 Cr
- Paid-Up Capital
₹1.00 Cr
- ROC Code
Roc Delhi
-
Listing Status
Unlisted
- Company Status
Active
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 1.00 Cr
- Company Age 8 Year, 9 Months
- Last Filing with ROC 31 Mar 2025
- Open Charges ₹ 6.65 Cr
- Satisfied Charges ₹ 1.00 M
- Revenue Growth -84.92%
- Profit Growth -96.22%
- Ebitda -94.31%
- Net Worth 6.32%
- Total Assets -34.53%
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Abhinav Goyal | Director | 01 Jan 2023 | Current |
| Amrita Sundaram | Director | 23 Jun 2021 | Current |
| Gaurav Garg | Director | 06 Apr 2017 | Current |
| Sahil Kalra | Director | 25 Dec 2017 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Nov 2021 | Past |
| Pramod Abcsdd | Director | 18 May 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Alpine Biomedicals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 84.92% decrease. The company also saw a substantial fall in profitability, with a 96.22% decrease in profit. The company's net worth moved up by a moderate rise of 6.32%.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
******* |
******* |
******* |
******* |
||
| Revenue from Operations |
|
******* |
******* |
******* |
******* |
||
| Total Assets |
|
******* |
******* |
******* |
******* |
||
| Profit or Loss |
|
*******
|
*******
|
*******
|
*******
|
||
| Net Worth |
|
*******
|
*******
|
*******
|
*******
|
||
| EBITDA |
|
******* |
******* |
******* |
******* |
In 2023, Alpine Biomedicals had a promoter holding of 60.00% and a public holding of 40.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
-
Promoters: 92.83%
-
Public: 4.10%
-
Others: 3.07%
| FY (2024) | FY (2023) | FY (2022) | FY (2021) | FY (2020) | |
|---|---|---|---|---|---|
| Promoters | 92.83 | 94.62 | 94.55 | 94.55 | 94.55 |
| Public | 4.10 | 3.89 | 3.95 | 3.96 | 3.98 |
| Others | 3.07 | 1.49 | 1.50 | 1.49 | 1.47 |
Reveal ownership structures and financial performance - Get instant access now!
₹66,500,000.00
₹1,000,000.00
- Others : 4.50 Cr
- Hdfc Bank Limited : 2.15 Cr
| Date | Lender | Amount | Status |
|---|---|---|---|
| 12 Jul 2024 | Others | ₹4.50 Cr | Open |
| 30 Sep 2021 | Hdfc Bank Limited | ₹2.15 Cr | Open |
| 06 Jun 2018 | Others | ₹1.00 M | Satisfied |
Explore comprehensive loan charge details -
Alpine Biomedicals has a workforce of 15 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
| Employee Date | Number of Employees |
|---|---|
| 2020 | 78,000 |
| 2021 | 80,500 |
| 2022 | 83,200 |
| 2023 | 86,000 |
| 2024 | 89,500 |
| 2025 | 92,000 |
Gain comprehensive insights into the Deals and Valuation data of Alpine Biomedicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Alpine Biomedicals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
What is the CIN of Alpine Biomedicals Private Limited?
The CIN of Alpine Biomedicals Private Limited is U85200HR2017PTC068487.
Where is Alpine Biomedicals Private Limited headquartered?
Alpine Biomedicals Private Limited is headquartered at Plot No 348, Sector 2, Industrial Growth Centre, Hsidc, Saha, Ambala, Haryana, 133104.
When was Alpine Biomedicals Private Limited incorporated?
Alpine Biomedicals Private Limited was incorporated on 06 April 2017.
Who are the current directors of Alpine Biomedicals Private Limited?
The current directors of Alpine Biomedicals Private Limited are
What is the primary industry of Alpine Biomedicals Private Limited?
The primary industry of Alpine Biomedicals Private Limited is Manufacturing.
Is Alpine Biomedicals Private Limited a listed company?
Alpine Biomedicals Private Limited is unlisted.
What is the capital structure of Alpine Biomedicals Private Limited?
The authorized capital of Alpine Biomedicals Private Limited is ₹1.00 Cr, and the paid-up capital is ₹1.00 Cr.
What is the compliance status of Alpine Biomedicals Private Limited?
The compliance status of Alpine Biomedicals Private Limited is Compliant.
+91-XXXXXXXXXX